Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: Effects on cerebrospinal fluid markers of JC virus replication and immune response

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 95-99

  Giudici, Barbara ^a   Vaz, Beatriz ^c   Bossolasco, Simona ^a   Casari, Salvatore ^b   Brambilla, Anna Maria ^a   Lüke, Wolfgang ^d   Lazzarin, Adriano ^a   Weber, Thomas ^c   Cinque, Paola ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Institute of Infectious and Tropical Diseases   (Italy)

^c Neurological Clinic   (Germany)

^d GERMAN PRIMATE CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS DNA; ZIDOVUDINE;

ADULT; ANTIBIOTIC THERAPY; ANTIBODY PRODUCTION; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; MALE; NEURORADIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVERTANT; SURVIVAL; VIRUS IMMUNITY; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIBODIES, VIRAL; CEREBROSPINAL FLUID; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS REPLICATION;

EID: 0033956614     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313598     Document Type: Article

References (27)

1. Weber T, Major EO. Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact [review]. Intervirology 1997; 40:98-111.
2. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-1 infected patients: cerebrospinal fluid analysis by the polymerase chain reaction [review). AIDS 1997; 11:1-17.
3. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997; 176:250-4.
4. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV-1 infection. J Neurovirol 1998; 4:59-68.
5. Major EO, Amemiya EE, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus induced demyelinating disease of the human brain [review]. Clin Microbiol Rev 1992; 5:49-73.
6. Hall CD, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998; 338:1345-51.
7. Power C, Nath A, Aoki FY, Del Bigio M. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV-1 infection [letter]. N Engl J Med 1997; 336:661-2.
8. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5-Year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy [letter]. Lancet 1997; 349:850.
9. Domingo P, Guardiola JM, Iranzo A, Margall N. Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy [letter]. Lancet 1997; 349:1554-5.
10. Baqi M, Kurcharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy [letter]. AIDS 1997; 11:1526-7.
11. Cinque P, Casari S, Bertelli D. Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy [letter]. N Engl J Med 1998; 339:848-9.
12. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12:1149-54.
13. Miralles P, Berenguer J, Garcia de Viedma D, et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998; 12:2467-72.
14. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999; 52:623-5.
15. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996; 10:951-8.
16. Anderson J, Armstead R, Baker AC, et al. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med 1998; 128:1079-100.
17. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-60.
18. De Luca A, Giancola ML, Cingolani A, et al. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 1999; 28:624-8.
19. Taoufik Y, Gasnault J, Karaterki A, et al. Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 1998; 178:1816-20.
20. Garcia de Viedma D, Alonso R, Miralles P, Berenguer J, Rodriguez-Crixems M, Bouza E. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J Clin Microbiol 1999; 37:724-8.
21. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52:253-60.
22. Yiannoutsos CT, Major EO, Curfman B, et al. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 1999; 45:816-21.
23. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Transactivation of the JC virus late promoter by the tat protein of the type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 1990; 87:3479-83.
24. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis [review]. AIDS 1999; 13:1-22.
25. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351:252-5.
26. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998; 44:341-9.
27. Schlitt M, Morawetz RB, Bonnin J, et al. Progressive multifocal leukoencephalopathy: three patients diagnosed by brain biopsy, with prolonged survival in two. Neurosurgery 1986; 18:407-14.